Public health experts in service of journalism.
Health Desk
Rapid responses to health questions for fact-checkers and journalists.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Rapid responses to health questions for fact-checkers and journalists.
مقارنة بالعديد من نظرائه، فإن لقاح أسترازينيكا أسهل وأقل تكلفة في التصنيع والتخزين والنقل. ظهر بشكل بارز في استراتيجيات اللقاح في العديد من البلدان النامية والمتقدمة لهذه الأسباب.
يمكن للمتعايشين مع فيروس نقص المناعة البشرية أخذ لقاح ضد كوفيد-19 بشكل آمن. كجزء من عملية الترخيص التي تمر بها اللقاحات المتاحة قبل إتاحتها للتلقيح الشامل، تسمح التجارب السريرية للباحثين بإثبات سلامة اللقاح. شملت التجارب السريرية المستخدمة لاختبار سلامة لقاحات كوفيد-19 المصرح بها أشخاصًا مصابين بعدوى فيروس نقص المناعة البشرية، واعتبرت آمنة.
إلى الآن، لا توجد بيانات تفيد بأن لقاحات كوفيد-19 تؤثر على الخصوبة. البحث مستمر لمواصلة دراسة العلاقة بين لقاحات كوفيد-19 والخصوبة على المدى الطويل وللتأكد من عدم وجود مخاطر. يقول العديد من الخبراء أن كوفيد-19 أكثر ضررًا للحوامل أو اللواتي يأملن في الحمل من اللقاحات التي تقي منه.
لم تكن هناك دراسات واسعة النطاق حتى الآن لفحص الآثار الجانبية المحتملة لجرعة ثالثة من لقاح فايزر- بيونتك، ولكن من المحتمل أن تكون هناك نوبات أكثر حدة من الآثار الجانبية الشائعة التي تميل إلى الحدوث بعد الجرعة ثانية (مثل الصداع والتعب وآلام العضلات والحمى والتورم). لا يوجد دليل يثبت أن جرعة ثالثة قد تسبب زيادة معدلات الإصابة بالسرطان أو النوبات القلبية أو الوفاة بين أولئك الذين تلقوا اللقاح.
لم تظهر الأبحاث الحالية وجود صلة بين لقاحات الحمض الريبي النووي المرسال ضد كوفيد-19 وجلطات الدم. يستمر قادة الصحة حول العالم في تشجيع الجميع على الحصول على لقاح كوفيد-19 عندما يكون متاحًا لهم.
تجربة التحدي البشري (HCT) هي دراسة يصاب فيها المتطوعون بالفيروس عن عمد وذلك عن طريق تلقيحهم لمعرفة مدى فاعلية اللقاح. عادة ما تسمح التجارب السريرية للمشاركين بالتعرض لكوفيد-19 في حياتهم اليومية، ولكن في تجارب التحدي البشري يصاب المتطوعين بالعدوى عن عمد من أجل معرفة المزيد عن الفيروس والاستجابة المناعية والأدوية والعلاجات.
There is no evidence suggesting that increased male libido (i.e. sex drive) is a common side effect from approved COVID-19 vaccines. Similarly, there is no evidence suggesting that the approved COVID-19 vaccines lead to decreased male libido or fertility. Common side effects include pain at the injection site, fatigue, headache, joint and muscle pain, which have the potential to temporarily decrease libido while the vaccine recipient recovers from minor side effects.
यह स्पष्ट नहीं है कि टीके की हिचकिचाहट और टीके के दुष्प्रभावों के बारे में समाचार जैसे कारकों ने दैनिक टीकाकरण दरों में गिरावट में कैसे योगदान दिया। हम वैक्सीन प्राप्त करने वाले लोगों की संख्या में गिरावट का श्रेय संभवतः कई चीजों के संयोजन को दे सकते हैं।
في الفلبين، لقاحات كوفيد-19 المتاحة هي سينوفاك بيوتيك وأسترازينيكا وفايزر بيونتيك وموديرنا ولقاح شركة جونسون أند جونسون ولقاح سبوتنيك V.
ليس من الواضح كيفية مساهمة عوامل مثل تردد اللقاح وأخبار عن الآثار الجانبية للقاح في انخفاض معدلات التلقيح اليومية. يمكننا على الأرجح أن نعزو الانخفاض في عدد الأشخاص الذين يحصلون على جرعات إلى مجموعة من الأمور.
The blood of people who have received a COVID-19 vaccine is not visibly darker than the blood of vaccinated people.
تُوقف التجارب السريرية مؤقتًا أو تعلّق بشكل متكرر عند تطوير أدوية ولقاحات جديدة. وذلك لأن كل تجربة سريرية يُشرف عليها من قبل مجلس مراقبة البيانات والسلامة الذي يبحث بشكل روتيني في البيانات من مراحل التجربة المختلفة لمعرفة ما إذا كانت هناك أي مشكلات ضارة أو عكسية تحدث للمشاركين في التجربة. ويرصد المجلس أيضًا لمعرفة إذا ما كان هناك أي دليل على فعالية اللقاح. إذا كان لدى مجلس الإدارة أية مخاوف أثناء أية مرحلة خلال أحد التجارب السريرية، فسوف يقترح إيقاف التجربة ليتمكنوا من تحديد: أ) سبب إصابة المريض (المرضى) بمشكلةٍ طبيةٍ ضارةٍ. ب) إذا كان المتلقين للقاح في التجارب السريرية في حالٍ أفضل ممن لم يتلقاه، ج) أو إذا كان حالُ المتلقين للقاح أسوأ بكثير ممن لم يتلقاه. وقد تنذر هذه الفحوصات المجدولة مسبقًا من قبل المجالس بالخطر، لكنها تحدث كثيرًا في جميع مراحل التجارب السريرية. مع انتقال اللقاحات إلى المراحل الثالثة من التجارب السريرية، والتي تُعطى لعشرات الآلاف من الأشخاص، فليس من الغريب أن يعاني شخص أو أكثر من مشكلة طبية قد تكون متعلقة أو غير متعلقة باللقاح ذاته. وتأتي قوائم الآثار الجانبية التي تراها على الأدوية من مراحل التجارب السريرية هذه. كما تحتوي الدراسات أيضًا على بروتوكولاتٍ ومعاييرٍ محددة مسبقًا، تحدد الأحداث التي ستؤدي إلى توقف مراحل البحث لفترة مؤقتة أو بشكل نهائي. ولا يمكنهم الاستمرار في التجربة من الناحية الأخلاقية، إذا كانت لديهم أسباب للقلق بشأن صحة المشاركين في التجارب السريرية الذين تلقوا لقاحاتهم.
Madalas mangyari ang paghinto o pagsususpinde ng mga klinikal na pagsubok sa pagbuo ng mga bagong gamot at bakuna. Nangyayari ito dahil pinapangasiwaan ang bawat klinikal na pagsubok ng isang lupon na nagbabantay sa datos at kaligtasan na regular na sumusuri sa datos na mula sa iba’t ibang yugto ng pagsubok para malaman kung may anumang nakakasama o hindi magandang nangyayari sa mga kalahok ng pagsubok. Nagbabantay rin ang lupon para malaman kung may anumang katibayan ng pagiging mabisa ng bakuna. Kung magkaroon ng anumang alalahanin ang lupon sa anumang bahagi ng klinikal na pagsubok, imumungkahi nilang ihinto ang pagsubok hanggang sa matukoy nila a) ang sanhi ng pagkakaroon ng (mga) pasyente ng nakakasamang isyung medikal, b) kung mas maganda ang kondisyon ng mga taong nakakatanggap ng bakuna sa mga klinikal na pagsubok kumpara sa mga taong hindi nakakatanggap nito, o c) kung mas masama ang kondisyon ng mga taong nakatanggap sa bakuna kumpara sa mga taong hindi nakatanggap nito. Maaaring nakakabahala ang mga nakatakda nang pagsusuri na ito ng mga lupon, pero madalas mangyari ang mga ito sa lahat ng yugto ng mga klinikal na pagsubok. Sa pagpasok ng mga bakuna sa mga ikatlong yugto ng mga klinikal na pagsubok, kung saan ibibigay ang mga ito sa libo-libong tao, hindi nakakagulat kung magkakaroon ng isyung medikal ang ilang tao na maaaring nauugnay sa mismong bakuna o hindi. Mula sa mga yugtong ito ng klinikal na pagsubok ang mga listahan ng mga side effect na nakikita sa mga gamot. Mayroon ding mga paunang nakatakdang protokol at pamantayan ang mga pag-aaral na tumutukoy kung anong mga pangyayari ang magiging dahilan ng paghinto o pagtigil nila sa mga yugto ng pananaliksik nila. Hindi nila maaaring ipagpatuloy ang pagsubok ayon sa etika kung may mga dahilan para mag-alala sila para sa kalusugan ng mga kalahok ng klinikal na pagsubok na nakatanggap sa mga bakuna nila.
नई दवाओं और टीकों के विकास में नैदानिक परीक्षण को विराम देना या निलंबित करना अक्सर होता है। ऐसा इसलिए है क्योंकि प्रत्येक नैदानिक परीक्षण की निगरानी एक डेटा और सुरक्षा निगरानी बोर्ड द्वारा की जाती है जो नियमित रूप से विभिन्न परीक्षण चरणों के डेटा को देखता है ताकि यह देखा जा सके कि क्या परीक्षण प्रतिभागियों में कोई हानिकारक या प्रतिकूल समस्या हो रही है। बोर्ड इस बात की भी निगरानी करता है कि क्या टीके के प्रभावी होने के कोई साक्ष्य है? यदि नैदानिक परीक्षण के दौरान किसी भी समय बोर्ड को कोई चिंता है, तो वे परीक्षण को तब तक रोकने का सुझाव देंगे जब तक कि वे यह निर्धारित नहीं कर लेते हैं कि a) रोगी(यों) में एक हानिकारक चिकित्सा समस्या का कारण क्या है, b) यदि नैदानिक परीक्षण में टीका प्राप्त करने वाले व्यक्ति टीका नहीं प्राप्त करने वाले व्यक्तियों की तुलना में बहुत स्वस्थ्य हैं, या c) टीका प्राप्त करने वाले व्यक्ति टीका नहीं प्राप्त करने वाले व्यक्तियों की तुलना में बहुत बीमार हैं। बोर्ड द्वारा ये पूर्व-निर्धारित जांच खतरनाक लग सकती हैं, लेकिन ये नैदानिक परीक्षण के सभी चरणों में अक्सर होती हैं। जैसे-जैसे टीके नैदानिक परीक्षणों के तीसरे चरण में प्रवेश करते हैं, जिसमें उन्हें दसियों हज़ार लोगों को दिया जाता है, इसमें कोई आश्चर्य नहीं है कि एक या अधिक लोग कोई चिकित्सा समस्या विकसित कर लें जो स्वयं टीके से संबंधित हो भी सकती है और नहीं भी। दुष्प्रभावों की सूची जो आप दवाओं पर देखते हैं वे इन नैदानिक परीक्षण चरणों से ही मालूम की जाती हैं। अध्ययनों में पूर्व-निर्धारित प्रोटोकॉल और मानदंड भी होते हैं जो यह निर्धारित करते हैं कि कौन सी घटनाएँ उन्हें अपने अन्वेषण चरणों को रोकने या रोकने का कारण बनेंगी। वे नैतिक रूप से परीक्षण जारी नहीं रख सकते हैं यदि उनके पास अपने टीके प्राप्त करने वाले नैदानिक परीक्षण प्रतिभागियों के स्वास्थ्य के बारे में चिंता के कारण हैं।
Evidence of the Molnupiravir's safety and effectiveness was strong enough for the independent board of medical experts monitoring the study to recommend that the clinical trials be stopped early, before enrolling and studying all of the 1,550 intended participants, enabling the drug to proceed with regulatory approval processes. In contrast, there is currently no evidence that Ivermectin is effective against COVID-19, including a large study showing no benefit compared to a placebo and another flawed study being withdrawn from a pre-print platform.
Health Desk provides on-demand and on-deadline science information to users seeking to quickly communicate complex topics to audiences.
In-house scientists provide custom explainers for critical science questions from journalists, fact-checkers and others in need of accessible breakdowns on scientific information. Topics range from reproductive health, infectious disease, climate science, vaccinology or other health areas.
Meedan's Health-Desk.org makes every effort to provide health- and science-related information that is accurate and reflects the best evidence available at the time of publication. To submit an error or correction request, please email our editorial team at health@meedan.com. All error or correction requests will be reviewed by the Health Desk Editorial and Science Teams. Where there is evidence of a factual error or typo, we will update the explainer with a correction or clarification and follow up with the reader on the status of the request.
Our scientists, writers, journalists, and experts do not engage in, advocate for, or publicize their personal views on policy issues that might lead a reasonable member of the public to see our team’s work as biased. If you have concerns or comments about potential bias in our work, please contact our editorial team at health@meedan.com.
Health Desk provides on-demand and on-deadline science information to users seeking to quickly communicate complex topics to audiences.
In-house scientists provide custom explainers for critical science questions from journalists, fact-checkers and others in need of accessible breakdowns on scientific information. Topics range from reproductive health, infectious disease, climate science, vaccinology or other health areas.
Meedan's Health-Desk.org makes every effort to provide health- and science-related information that is accurate and reflects the best evidence available at the time of publication. To submit an error or correction request, please email our editorial team at health@meedan.com. All error or correction requests will be reviewed by the Health Desk Editorial and Science Teams. Where there is evidence of a factual error or typo, we will update the explainer with a correction or clarification and follow up with the reader on the status of the request.
Our scientists, writers, journalists, and experts do not engage in, advocate for, or publicize their personal views on policy issues that might lead a reasonable member of the public to see our team’s work as biased. If you have concerns or comments about potential bias in our work, please contact our editorial team at health@meedan.com.
Nat Gyenes, MPH, leads Meedan’s Digital Health Lab, an initiative dedicated to addressing health information equity challenges, with a focus on the role that technology plays in mediating access to health through access to information. She received her masters in public health from the Harvard T. H. Chan School of Public Health, with a focus on equitable access to health information and human rights. As a research affiliate at Harvard’s Berkman Klein Center for Internet & Society, she studies the ways in which health information sources and outputs can impact health outcomes. She lectures at the Harvard T.H. Chan School of Public Health on Health, Media and Human Rights. Before joining Meedan, Nat worked at the MIT Media Lab as a health misinformation researcher.
Megan Marrelli is a Peabody award-winning journalist and the News Lead of Health Desk. She focuses on news innovation in today’s complex information environment. Megan has worked on the digital breaking news desk of the Globe and Mail, Canada’s national newspaper, and on the news production team of the Netflix series Patriot Act with Hasan Minhaj. She was a Canadian Association of Journalists finalist for a team Chronicle Herald investigation into house fires in Halifax, Nova Scotia. On top of her role at Meedan Megan works with the investigative journalism incubator Type Investigations, where she is reporting a data-driven story on fatal patient safety failures in U.S. hospitals. She holds a Master of Science from the Columbia Journalism School and lives in New York.
Anshu holds a Doctor of Public Health (DrPH) from the Harvard T.H. Chan School of Public Health, and a Humanitarian Studies, Ethics, and Human Rights concentrator at the Harvard Humanitarian Initiative. She is a Harvard Voices in Leadership writing fellow and student moderator, Prajna Fellow, and the John C. and Katherine Vogelheim Hansen Fund for Africa Awardee. Anshu’s interests include: systemic issues of emergency management, crisis leadership, intersectoral approaches to climate risk resilience, inclusion and human rights, international development, access and sustainability of global health systems, and socio-economic equity. Anshu has worked at the United Nations, UNDP, UNICEF, Gates Foundation, and the Institute of Healthcare Improvement.
Dr. Christin Gilmer is a Global Health Scientist with a background in infectious diseases, international health systems, and population health and technology. In the last 15 years, Christin has worked for the WHO, University of Oxford, World Health Partners, USAID, UNFPA, the FXB Center for Health & Human Rights and more, including volunteering for Special Olympics International’s health programs and running health- and technology-based nonprofits across the country. She obtained her Doctor of Public Health Degree at the Harvard T.H. Chan School of Public Health, her MPH at Columbia, and spent time studying at M.I.T., Harvard Kennedy School, and Harvard Business School. Christin has worked in dozens of countries across five continents and loves running programs and research internationally, but she is currently based in Seattle.
Dr. Jessica Huang is currently a COVID-19 Response and Recovery Fellow with the Harvard Kennedy School’s Bloomberg City Leadership Initiative. Previously, she worked and taught with D-Lab at MIT, leading poverty reduction and humanitarian innovation projects with UNICEF, UNHCR, Oxfam, USAID, foreign government ministries and community-based organizations across dozens of countries. She also co-founded a social enterprise that has provided access to safe drinking water to thousands in India, Nepal and Bangladesh. Formerly trained as an environmental engineer, she earned a Doctorate of Public Health from Harvard and a Master’s in Learning, Design and Technology (LDT) from Stanford. Her projects have won multiple awards, including the top prize in A Grand Challenge for Development: Technology to Support Education in Crisis & Conflict Settings, and led to her being recognized for Learning 30 Under 30. She enjoys being an active volunteer, supporting several non-profits in health, education, environmental sustainability and social justice.
Jenna Sherman, MPH, is a Program Manager for Meedan’s Digital Health Lab, an initiative focused on addressing the urgent challenges around health information equity. She has her MPH from the Harvard T.H. Chan School of Public Health in Social and Behavioral Sciences, with a concentration in Maternal and Child Health. Prior to her graduate studies, Jenna served as a Senior Project Coordinator at the Berkman Klein Center for Internet and Society at Harvard Law School, where she worked on tech ethics with an emphasis on mitigating bias and discrimination in AI and health misinformation online. Previous experiences include helping to develop accessible drug pricing policies, researching access to quality information during epidemics, and studying the impact of maternal incarceration on infant health.
Nour is a Global Health Strategy consultant based in Dakar (Senegal) and specialized in health system strengthening. Most recently, she worked with Dalberg Advisors focusing on Epidemic Preparedness & Response and Vaccination Coverage and Equity across 15 countries in Sub-Saharan Africa. Her previous work experiences include researching the clinical needs in point-of-care technology in cancer care at the Dana-Farber Cancer Institute in Boston; and coordinating the implementation of a colonoscopy quality assurance initiative for a colorectal cancer screening program at McGill University in Montreal. Nour has a Master of Public Health from the Harvard T.H. Chan School of Public Health, a Master of Arts in Medical Ethics and Law from King’s College London, and a Bachelor of Science from McGill University. She is fluent in French and English.
Shalini Joshi is a Program Lead at Meedan and formerly the Executive Editor and co-founder of Khabar Lahariya - India’s only independent, digital news network available to viewers in remote rural areas and small towns. Shalini transformed Khabar Lahariya from one edition of a printed newspaper to an award-winning digital news agency available to over ten million viewers. She has a sophisticated understanding of local media and gender, and the ways in which they can inhibit women from participating in the public sphere in South Asia. Shalini was a TruthBuzz Partner & Fellow with the International Center for Journalists (ICFJ). She is a trainer in journalism, verification and fact-checking. She has designed, implemented and strengthened news reporting & editorial policies and practices in newsrooms and fact-checking organisations. Shalini set up and managed the tipline used to collect WhatsApp-based rumors for Checkpoint, a research project to study misinformation at scale during the 2019 Indian general elections.
Mohit Nair currently serves as Partnerships Director at FairVote Washington, a non-profit organisation based in Seattle, WA. Previously, he worked with the Medecins Sans Frontieres (MSF) Vienna Evaluation Unit and with MSF Operational Centre Barcelona in India. He has conducted research studies on diverse topics, including the drivers of antibiotic resistance in West Bengal and perceptions of palliative care in Bihar. Mohit has also worked as a research consultant with Save the Children in Laos to identify gaps in the primary health system and develop a district-wide action plan for children with disabilities. He holds a Master of Public Health from the Harvard University T.H. Chan School of Public Health and a Bachelor of Science from Cornell University.
Seema Yasmin is an Emmy Award-winning medical journalist, poet, physican and author. Yasmin served as an officer in the Epidemic Intelligence Service at the U.S. Centers for Disease Control and Prevention where she investigated disease outbreaks. She trained in journalism at the University of Toronto and in medicine at the University of Cambridge. Yasmin was a finalist for the Pulitzer Prize in breaking news in 2017 with a team from The Dallas Morning News and received an Emmy Award for her reporting on neglected diseases. She received two grants from the Pulitzer Center on Crisis Reporting and was selected as a John S. Knight Fellow in Journalism at Stanford University iin 2017 where she investigated the spread of health misinformation and disinformation during epidemics.
Dr. Saskia Popescu is an infectious disease epidemiologist and infection preventionist with a focus on hospital biopreparedness and the role of infection prevention in health security efforts. She is an expert in healthcare biopreparedness and is nationally recognized for her work in infection prevention and enhancing hospital response to infectious diseases events. Currently, Dr. Popescu is an Adjunct Professor with the University of Arizona, and an Affiliate Faculty with George Mason University, while serving on the Coronavirus Task Force within the Federation of American Scientists, and on a data collection subcommittee for SARS-CoV-2 response with the National Academies of Science, Engineering, and Medicine. She holds a PhD in Biodefense from George Mason University, a Masters in Public Health with a focus on infectious diseases, and a Masters of Arts in International Security Studies, from the University of Arizona. Dr. Popescu is an Alumni Fellow of the Emerging Leaders in Biosecurity Initiative (ELBI) at the Johns Hopkins Bloomberg School of Public Health, Center for Health Security. She is also an external expert for the European Centre for Disease Control (ECDC), and a recipient of the Presidential Scholarship at George Mason University. In 2010, she was a recipient of the Frontier Interdisciplinary eXperience (FIX) HS-STEM Career Development Grant in Food Defense through the National Center for Food Protection and Defense. During her work as an infection preventionist, she managed Ebola response, a 300+ measles exposure resulting in an MMWR article, and bioterrorism preparedness in the hospital system. More recently, she created and disseminated a gap analysis for a 6-hospital system to establish vulnerabilities for high-consequence diseases, helping to guide the creation of a high-consequence disease initiative to enhance readiness at the healthcare level.
Ben Kertman is a behavior change scientist and public health specialist who became a user research consultant to help organizations design experiences that change behaviors and improve human well-being. Impatient with the tendency of behavior change companies to use a single discipline approach (e.g. behavioral economics) and guard their methods behind paywalls, Ben spent the last 7 years developing an open-source, multi-discipline, behavior change framework for researchers and designers to apply to UX. Ben is an in-house SME at Fidelity Investments and consults for non-profits on the side. Ben holds a masters in Social and Behavior Science and Public Health from Harvard.
Emily LaRose is a Registered Dietitian and Nutrition and Global Health Consultant who, in addition to her work with Meedan, currently works as a Technical Advisor for Nutrition for Operation Smile. She has been a dietitian for more than 18 years and, over the past 10 years, she has worked for the World Bank, Global Alliance for Improved Nutrition (GAIN), Médecins Sans Frontières (MSF), PATH, Johnson & Wales University, and Children’s Hospital Los Angeles. In her work, she has conducted analytical research and written specialty reports on infant and young child malnutrition, health misinformation, global human milk banking practices, and innovative food system programs; developed tools and protocols for clinical nutrition care delivery in humanitarian hospitals; taught university-level nutrition courses; and provided nutritional care for critically ill hospitalized patients. Emily earned her Doctor of Public Health (DrPH) degree with a Nutrition and Global Health Concentration at the Harvard T.H. Chan School of Public Health, her Master of Science in Dietetics at Kansas State University, and her Bachelor of Science in Culinary Arts Nutrition at Johnson & Wales University.
Bhargav Krishna is a Fellow at the Centre for Policy Research in Delhi, and adjunct faculty at the Public Health Foundation of India and Azim Premji University. He previously managed the Centre for Environmental Health at the Public Health Foundation of India, leading research and teaching on environmental health at the Foundation. He has been a member of Government of India expert committees on air pollution and biomedical waste, and has led work with Union and State governments on air pollution, climate change, and health systems. His work has been funded by the World Health Organization, Rockefeller Foundation, Packard Foundation, Environmental Defense Fund, and others. He holds bachelors and masters degrees in Biotechnology and Environmental Science respectively, and graduated recently from the Doctor of Public Health program at the Harvard T. H. Chan School of Public Health. Bhargav also co-founded Care for Air, a non-profit working on raising awareness related to air pollution with school children in Delhi.
Dr. Christine Mutaganzwa is a medical doctor pursuing a Ph.D. program at the Université de Montréal in Biomedical Sciences. She holds a Master of Medical Sciences in Global Health Delivery (MMSc-GHD) from Harvard Medical School, Boston, MA, and a Master of Sciences (MSc) in Epidemiology and Biostatistics from the University of Witwatersrand, Johannesburg, South Africa. She graduated from the University of Rwanda with a degree in General Medicine and Surgery. Christine has worked with referral hospitals in Kigali, the capital city of Rwanda, during her medical training and after graduation. In addition, she has extensive experience working with rural communities in the Eastern province of Rwanda, where she organized clinical and research activities in active collaboration with colleagues within and outside Rwanda. Her research portfolio cuts across maternal and child health to infectious and chronic diseases. Christine is an advocate for children's healthcare services, especially for underserved populations. She is part of a community of scientists translating scientific findings into understandable and accessible information for the general population. Christine is an avid reader and a lover of classical/contemporary music.
Ahmad is an experienced physician, who earned his medical degree from Cairo University, Faculty of Medicine, in Egypt. He practiced medicine between 2012 and 2017 as a general practitioner where he was involved in primary care, health quarantine services, and radiology. He then taught medicine in Cairo for two years prior to starting his MPH program, at the Harvard T.H. Chan School of Public Health, where he supplemented his experience with knowledge on epidemiology, health systems and global health issues. Additionally, Ahmad has an interest in nutrition, which started as a personal curiosity to how he can improve his own health, then quickly saw the potential for public health nutrition in the prevention and management of multiple, lifelong diseases. His enrollment at Harvard started his transition towards learning about food, and public health nutrition. Ahmad now combines the knowledge and experience of his medical career, with the learnings of his degree to navigate public health topics in his writing and his career. He is a life-long learner and continues to gather knowledge and experience, and works towards maximizing his impact through combatting misinformation through his work with Meedan.
Dr. Uzma Alam is a global health professional working at the intersection of infectious diseases and healthcare delivery in the international development and humanitarian contexts. She focuses on the use of evidence and innovation to inform strategies and policies. Her work has appeared globally across print and media outlets.She has international experience with roles of increasing responsibility across the science value chain having served with academic, non-profit, corporate, and governmental agencies, including advisory commissions and corporate counsel. Uzma is the former secretary of the Association of Women in Science and editor of the Yale Journal of Health Policy, Law, and Ethics. Currently she serves on the Board of the Geneva Foundation. She also leads the Biomedical and Health Sciences Portfolio of the Developing Excellence, Leadership and Training in Science in Africa program (DELTAS-Africa). A US$100 million programme supporting development of world-class scientific leaders on the continent. Plus heading the African Science, Technology, and Innovation (STI) Priorities Programme. A programme that engages Africa’s science and political leaders to identify the top STI priorities for the continent that if addressed, offer the highest return on investment for Africa’s sustainable development.
